Non-secreting benign glucagonoma diagnosed incidentally in a patient with refractory thrombocytopenic thrombotic purpura: report of a case

Surg Today. 2015 Oct;45(10):1317-20. doi: 10.1007/s00595-014-1073-3. Epub 2014 Nov 6.

Abstract

Thrombotic thrombocytopenic purpura (TTP) is a rare hematologic disorder, which may be idiopathic or secondary to a variety of diseases. However, there are very few reports of TTP in the context of pancreatic neoplasms. We report a case of relapsing TTP after initial treatment with plasmapheresis, corticosteroids, and rituximab, in a 59-year-old woman. During diagnostic work-up, a pancreatic lesion 35 × 25 mm in size was discovered incidentally and splenopancreatectomy was performed. The pathological diagnosis was benign glucagonoma. The hematological symptoms resolved completely after the procedure and 3 years later, the patient is well with no sign of recurrence of TTP or glucagonoma. To our knowledge, this represents the first documented case of a non-secreting benign pancreatic neuroendocrine tumor (glucagonoma) associated with TTP that is refractory to standard treatment.

Keywords: Glucagonoma; Pancreatectomy; Plasmapheresis; Splenectomy; TTP.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Glucagonoma / complications*
  • Glucagonoma / diagnosis*
  • Glucagonoma / pathology
  • Glucagonoma / therapy
  • Humans
  • Incidental Findings*
  • Middle Aged
  • Pancreatectomy
  • Pancreatic Neoplasms / complications*
  • Pancreatic Neoplasms / diagnosis*
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / therapy
  • Plasmapheresis
  • Prednisolone / analogs & derivatives
  • Prednisolone / therapeutic use
  • Purpura, Thrombotic Thrombocytopenic / etiology*
  • Purpura, Thrombotic Thrombocytopenic / therapy*
  • Recurrence
  • Rituximab / therapeutic use
  • Splenectomy
  • Treatment Failure

Substances

  • Rituximab
  • Prednisolone
  • prednylidene